DE69329347T2 - Immunreaktive peptide des epstein-barrvirus - Google Patents

Immunreaktive peptide des epstein-barrvirus

Info

Publication number
DE69329347T2
DE69329347T2 DE69329347T DE69329347T DE69329347T2 DE 69329347 T2 DE69329347 T2 DE 69329347T2 DE 69329347 T DE69329347 T DE 69329347T DE 69329347 T DE69329347 T DE 69329347T DE 69329347 T2 DE69329347 T2 DE 69329347T2
Authority
DE
Germany
Prior art keywords
immunreactive
peptides
epstein
barrvirus
epstein barrvirus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69329347T
Other languages
English (en)
Other versions
DE69329347D1 (de
Inventor
S Smith
R Pearson
D Parks
Susan Pothen Varghese
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ortho Clinical Diagnostics Inc
Original Assignee
Georgetown University
Ortho Clinical Diagnostics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Georgetown University, Ortho Clinical Diagnostics Inc filed Critical Georgetown University
Publication of DE69329347D1 publication Critical patent/DE69329347D1/de
Application granted granted Critical
Publication of DE69329347T2 publication Critical patent/DE69329347T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16211—Lymphocryptovirus, e.g. human herpesvirus 4, Epstein-Barr Virus
    • C12N2710/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE69329347T 1992-09-15 1993-09-15 Immunreaktive peptide des epstein-barrvirus Expired - Lifetime DE69329347T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US94528092A 1992-09-15 1992-09-15
PCT/US1993/008699 WO1994006470A1 (en) 1992-09-15 1993-09-15 Immunoreactive peptides from epstein-barr virus

Publications (2)

Publication Number Publication Date
DE69329347D1 DE69329347D1 (de) 2000-10-05
DE69329347T2 true DE69329347T2 (de) 2001-10-31

Family

ID=25482904

Family Applications (2)

Application Number Title Priority Date Filing Date
DE69334276T Expired - Lifetime DE69334276D1 (de) 1992-09-15 1993-09-15 Immunreaktive peptide des epstein-barrvirus
DE69329347T Expired - Lifetime DE69329347T2 (de) 1992-09-15 1993-09-15 Immunreaktive peptide des epstein-barrvirus

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE69334276T Expired - Lifetime DE69334276D1 (de) 1992-09-15 1993-09-15 Immunreaktive peptide des epstein-barrvirus

Country Status (11)

Country Link
EP (2) EP0889052B1 (de)
JP (2) JP3756944B2 (de)
AT (2) ATE195950T1 (de)
AU (1) AU693421B2 (de)
CA (1) CA2143642C (de)
DE (2) DE69334276D1 (de)
DK (1) DK0671946T3 (de)
ES (1) ES2149822T3 (de)
GR (1) GR3034972T3 (de)
PT (1) PT671946E (de)
WO (1) WO1994006470A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7326535B2 (en) 1993-09-15 2008-02-05 Ortho Diagnostic Systems Inc. Immunoreactive peptides from Epstein-Barr virus
US7060283B1 (en) 1992-09-15 2006-06-13 Ortho Diagnostic Systems, Inc. Immunoreactive peptides from Epstein-Barr virus
US6506553B1 (en) * 1995-03-30 2003-01-14 Ortho Diagnostics Systems, Inc. Method for diagnosis of Epstein-Barr virus associated disease
JP3618497B2 (ja) * 1996-12-27 2005-02-09 富士通株式会社 タンパク質の抗原決定基予測方法及びシステム
FR2791142B1 (fr) * 1999-03-17 2001-06-22 Univ Grenoble 1 Utilisation de la brefeldine a pour augmenter l'effet de presentation d'antigenes exogenes par les cpa
GB9916529D0 (en) * 1999-07-14 1999-09-15 Chiron Spa Antigenic peptides
EP2101177A1 (de) * 2008-03-10 2009-09-16 Universite Joseph Fourier Verwendung eines synthetischen Peptids aus dem ZEBRA-Protein für die in-vitro-Diagnose von Epstein-Barr-Virus (EBV)-Reaktivierung
MA44334A (fr) 2015-10-29 2018-09-05 Novartis Ag Conjugués d'anticorps comprenant un agoniste du récepteur de type toll

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3583564D1 (de) * 1984-08-23 1991-08-29 Hans Joachim Wolf Dna-sequenzen des ebv-genoms, rekombinante dna-molekuele, verfahren zur herstellung von ebv-verwandten antigenen sowie diagnostische zusammensetzungen und pharmazeutische zusammensetzungen, die die genannten antigene enthalten.
US4879213A (en) * 1986-12-05 1989-11-07 Scripps Clinic And Research Foundation Synthetic polypeptides and antibodies related to Epstein-Barr virus early antigen-diffuse
WO1991008224A1 (en) * 1989-11-24 1991-06-13 The Council Of The Queensland Institute Of Medical Research Im peptides

Also Published As

Publication number Publication date
EP0889052A2 (de) 1999-01-07
AU693421B2 (en) 1998-07-02
DK0671946T3 (da) 2000-11-13
ATE428724T1 (de) 2009-05-15
GR3034972T3 (en) 2001-02-28
DE69329347D1 (de) 2000-10-05
EP0671946A1 (de) 1995-09-20
EP0671946B1 (de) 2000-08-30
JP3757220B2 (ja) 2006-03-22
ATE195950T1 (de) 2000-09-15
EP0671946A4 (de) 1995-11-29
EP0889052A3 (de) 1999-08-18
CA2143642A1 (en) 1994-03-31
ES2149822T3 (es) 2000-11-16
AU4922793A (en) 1994-04-12
JP2004057208A (ja) 2004-02-26
DE69334276D1 (de) 2009-05-28
WO1994006470A1 (en) 1994-03-31
JP3756944B2 (ja) 2006-03-22
JPH08510714A (ja) 1996-11-12
PT671946E (pt) 2000-12-29
EP0889052B1 (de) 2009-04-15
CA2143642C (en) 2006-09-05

Similar Documents

Publication Publication Date Title
PT725824E (pt) Epitopos de celulas t humanas imunodominantes do virus da hepatite c
ATA257190A (de) Virales polypeptid
DK1266965T3 (da) Rekombinante antistoffer til human terapi
DE69636760D1 (de) Rekombinanter anti-cd4 antikörper zur menschlichen behandlung
DE69332485D1 (de) Immunmodulierende peptide
DE59209921D1 (de) Seroreaktive Bereiche auf den HPV 16 Proteinen E1 und E2
DK64592D0 (da) Peptider til terapeutisk behandling
KR890002547A (ko) Hiv 감염의 치료 및 진단용 모노클로날항체 및 펩티드
KR970702919A (ko) 재조합형의 인간면역부전바이러스 담체 및 그 제조방법(Recombinant Human Immunodeficiency Virus Vector and Process for Producing the same)
NO910209L (no) Fremgangsmaate for fremstilling av rekombinante humane anti-cd18-antistoffer.
DE69329347D1 (de) Immunreaktive peptide des epstein-barrvirus
DE69534325D1 (de) Peptide zur behandlung von krebs
ATE342920T1 (de) Methylierte smd homologe peptide, die mit antikörpern aus sera von lebewesen mit systemischer lupus erythematodes reagieren
ATE211148T1 (de) Hcmv-spezifische peptide und ihre verwendung
KR950700761A (ko) 사람 면역결핍 바이러스(HIV) 감염의 예방 및 치료를 위한 재조합 사람 HIV-중화 모노클로날 항체(Recombinant human HIV-neutralizing monoclonal antibodies for prevention and treatment of HIV infection)
GB9425604D0 (en) Peptides effective for diagnsis of hepatitis C infection
KR950702244A (ko) 백신으로서의 즉석 초기 hsv-2 비루스 단백질 icp27(immediatie early hsv-2 viral protein icp27 as vaccine)
DE69124795D1 (de) Neutrophile stimulierende peptide
DE69328488T2 (de) Peptide, analoge und ihre mischungen zur detektion und erzeugung von antikörpern gegen die e1 und e2 proteine des rubella virus
FR2737209B1 (fr) Peptide capable d'etre reconnu par des anticorps reconnaissant l'antigene c33 du virus de l'hepatite c
FI943929A (fi) Hepatiitti C-viruspeptidejä
IT9019699A0 (it) Procedimento di purificazione del b-interferone umano ricombinante
DE69420044D1 (de) Blutregulierende peptide
GB9209857D0 (en) Synthetic peptides of human papilloma virus
ATE414712T1 (de) Immunogenes hla-bindendes peptid und verwendung desselben zur hiv-infektionsbehandlung

Legal Events

Date Code Title Description
8327 Change in the person/name/address of the patent owner

Owner name: ORTHO-CLINICAL DIAGNOSTICS, INC., ROCHESTER, N.Y.,

8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: BOEHMERT & BOEHMERT, 28209 BREMEN